<b>Investigating association of chemokine receptor 5 (CCR5) polymorphism with cervical cancer in human papillomavirus (HPV) suggestive patients</b> - DOI: 10.4025/actascihealthsci.v30i2.944
Keywords:
cervical cancer, CCR5, HPV
Abstract
HPV is the most responsible of cervical cancer. It is known that chemokines are important determinants of the early inflammatory response. The CC chemokine receptor 5 (CCR5) gene is involved in the chemotaxis of leukocytes toward inflammation sites. In the present study, polymerase chain reactions (PCR) in genomic DNA samples, using specific CCR5 oligonucleotide primers surrounding the breakpoint deletion, detected a 225bp product from the normal CCR5 allele and a 193bp product from the 32bp deletion allele. The wild type genotype was prevalent in both group, but it wasn’t statistically significant with χ² =1,519 (2 degrees of freedom; p>0.05). Once there is a small number of 32 allele carriers, further studies are needed to clarify the role of CCR5 in the cervical cancer.Downloads
Download data is not yet available.
Published
2008-12-15
How to Cite
Suzuki, P. S., Oliveira, K. B. de, Aoki, M. N., Tatakihara, V. L. H., Borelli, S. D., & Watanabe, M. A. E. (2008). <b>Investigating association of chemokine receptor 5 (CCR5) polymorphism with cervical cancer in human papillomavirus (HPV) suggestive patients</b> - DOI: 10.4025/actascihealthsci.v30i2.944. Acta Scientiarum. Health Sciences, 30(2), 95-100. https://doi.org/10.4025/actascihealthsci.v30i2.944
Issue
Section
Clinical Analysis
DECLARATION OF ORIGINALITY AND COPYRIGHTS
I Declare that current article is original and has not been submitted for publication, in part or in whole, to any other national or international journal.
The copyrights belong exclusively to the authors. Published content is licensed under Creative Commons Attribution 4.0 (CC BY 4.0) guidelines, which allows sharing (copy and distribution of the material in any medium or format) and adaptation (remix, transform, and build upon the material) for any purpose, even commercially, under the terms of attribution.
Read this link for further information on how to use CC BY 4.0 properly.
5.png){kind=logo}
